Clinical Trials Directory

Trials / Completed

CompletedNCT05693285

Preterm Birth and Biomarkers for Cardiovascular Disease

Status
Completed
Phase
Study type
Observational
Enrollment
65 (actual)
Sponsor
Uppsala University · Academic / Other
Sex
Female
Age
60 Years
Healthy volunteers
Not accepted

Summary

Preterm birth is associated with maternal increased risk of cardiovascular disease later in life. In an observational case- control study, investigators want to evaluate whether women with preterm birth have increased levels of biomarkers for cardiovascular disease, to reveal potential pathophysiological mechanisms in common.

Detailed description

Women with spontaneous preterm birth in first pregnancy and a group of matched controls with spontaneous birth in normal time where invited to participate in the study. Participants were identified from the Biobank of Pregnant Women in Uppsala. Levels of cardiovascular biomarkers will be analyzed in plasma samples from the pregnancy and at a follow-up visit where investigators also collect information about other cardiovascular risk factors and lipid status.

Conditions

Interventions

TypeNameDescription
OTHERNo interventionNo intervention

Timeline

Start date
2022-11-14
Primary completion
2022-12-02
Completion
2022-12-02
First posted
2023-01-20
Last updated
2023-01-26

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT05693285. Inclusion in this directory is not an endorsement.

Preterm Birth and Biomarkers for Cardiovascular Disease (NCT05693285) · Clinical Trials Directory